AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Agreement reached to develop and market nasally administered apomorphine.
2002 MAR 14 - (NewsRx.com & NewsRx.net) -- Nastech Pharmaceutical Co., Inc., (NSTK) and Pharmacia Corp. (PHA) have inked an agreement for the development and marketing of Nastech's proprietary nasally administered apomorphine product for the treatment of erectile dysfunction (ED) and female sexual dysfunction (FSD).
Apomorphine is a dopamine agonist that promotes erectile function by stimulating the D1/D2 class of dopamine receptors in the brain that are responsible for the initiation of the erectile response. Nastech's proprietary nasal formulation is designed to maximize the rapid onset, therapeutic effect, and overall safety of apomorphine.
Under terms of the agreement, Pharmacia receives exclusive, worldwide rights to develop and market nasally administered apomorphine for the treatment of male and female sexual dysfunction and will manage and fund all future development in these indications. Nastech retains certain development rights in other therapeutic areas.
Nastech will receive an upfront payment at signing of $3.0 million and, upon ...
- Nastech Announces Positive Results from Phase II Clinical Trial of Nasally...
- Press release article from: PR Newswire December 13, 2001 700+ words
...that concluded its nasally administered apomorphine formulation demonstrated...support our belief that nasally administered apomorphine may be an attractive...trials indicated that nasally administered apomorphine has a maximum blood...
- Nastech and Pharmacia Reach Worldwide Agreement To Develop and Market Nasally...
- Press release article from: PR Newswire February 4, 2002 700+ words
...Nastech's proprietary nasally administered apomorphine product for the treatment...develop and market nasally administered apomorphine for the treatment...certain quantities of nasally administered apomorphine and will receive...
- Nastech Demonstrates Successful Delivery of Nasally Administered Interferon...
- Press release article from: PR Newswire March 21, 2002 700+ words
...1a as an intramuscular injection, or a 30-60 mcg nasally administered Interferon beta-1a spray of either Nastech's formulation...President and Chief Executive Officer of Nastech. "Nasally administered Interferon beta may potentially provide MS patients with...
- Nasally administered flu vaccine comes to United States.(Brief Article)
- Newspaper article from: Sports Medicine Reports Elliott, William T. August 1, 2003 700+ words
The FDA has approved the first nasally administered flu vaccine to be marketed in Medimmune's "FluMist" is also the first influenza vaccine to use live virus. This year's version...
- Nastech Files IND Application For Nasally Administered Buprenorphine Hcl
- Press release article from: PR Newswire October 6, 1997 700+ words
HAUPPAUGE, N.Y., Oct. 6 /PRNewswire/ -- Nastech Pharmaceutical Company Inc. (Nasdaq: NSTK) today announced the Company has filed an Investigational New Drug (IND) application with the U.S. Food and Drug Administration to begin initial clinical evaluation of nasally delivered buprenorphine
- Nastech Reports 2001 Financial Results.
- Press release article from: PR Newswire February 19, 2002 700+ words
...Pharmacia for our nasally administered apomorphine for erectile dysfunction...Pharmacia Partnership for Nasally Administered Apomorphine -- Nastech received...certain quantities of nasally administered apomorphine and will receive...
- Nastech Reacquires All Development and Commercialization Rights for Intranasal...
- Press release article from: PR Newswire April 17, 2003 700+ words
...addition to developing nasally administered apomorphine for treatment of...safety and efficacy of nasally administered apomorphine in increasing sexual...S. market for nasally administered apomorphine for ED treatment...
- NASTECH LICENSES ED PRODUCT TO PHARMACIA FOR UP TO $56M.(Brief Article)
- Magazine article from: BIOWORLD Today Coghill, Kim February 5, 2002 700+ words
...Nastech Pharmaceutical Co. Inc. licensed its nasally administered apomorphine product for sexual dysfunction in both men...Nastech will manufacture certain qualities of nasally administered apomorphine and will receive transfer payments from Pharmacia...
Source: HighBeam Research, Agreement reached to develop and market nasally administered...